Skip to main content
. 2017 Feb 16;8(19):30723–30733. doi: 10.18632/oncotarget.15413

Figure 8. Effect of DIOS on the expression and translocation of NF-κB(p65) after LPS/D-GalN administration.

Figure 8

A. Control, B. DIOS, C. LPS/D-GalN (LPS 10 μg/kg, D-GalN 400 mg/kg), and D. DIOS (50 mg/kg)+LPS/D-GalN are indicated in the representative photomicrographs of NF-κB (p65) immunoreactivity. E. and F. Cytosol and nucleus NF-κB (p65) expressions were determined by western blot analysis. All data are presented as means ± SD (n = 10). **P < 0.05, ***P < 0.01 vs control group; ###P < 0.01 vs LPS/D-GalN group.